Translational Research Examining Acupuncture Treatment in Traumatic Brain Injury
Completed · Not applicable · Has a placebo group
Conditions studied: Traumatic Brain Injury
In brief
The purpose of this study is to examine the effects of acupuncture on cerebral blood flow (CBF) and blood biomarkers during the acute 10-day window following traumatic brain injury, to determine if those changes correlate with changes in biomarkers of brain health, neuropsychological testing, and symptomatic presentation.
Key facts
- Study ID
- NCT02623218
- Run by
- AOMA Graduate School of Integrative Medicine
- People needed
- 22
- Starts
- 2015-11-01
- Expected to finish
- 2016-05-01
- Last updated by the study team
- 2020-01-28
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Age 18-50
- Documented TBI (for TBI-ACUP and TBI-SHAM arms)
- Visual acuity and hearing adequate for outcomes testing
- Fluency in English
- Ability to provide informed consent
- Acupuncture naïve
You may not qualify if…
- Significant polytrauma that may interfere with follow-up and outcome assessment
- Patients with major debilitating baseline mental health disorders that would interfere with the validity of outcome assessment due to TBI
- Patients on psychiatric hold
- Patients with major debilitating baseline neurological diseases impairing baseline awareness, cognition, or validity of outcome assessment due to TBI
- Significant history of pre-existing conditions that would interfere with the likelihood of follow-up and validity of outcome assessment due to TBI
- Pregnancy in female subjects
- Prisoners or patients in custody
- Current participation in an observational or intervention trial for TBI
- Non-English speakers
Where it is running
- Healing Response Acupuncture & Integrative Medicine — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.